Sandra Lee is a partner in the Intellectual Property Practice in the firm’s New York office. Ms. Lee’s work is focused in the pharmaceutical, chemical, medical device and consumer products areas.
Ms. Lee has a full spectrum practice that includes a broad range of client counseling and strategic portfolio development and management. She has been involved in supporting numerous post-grant proceedings, and she counsels clients in Orange Book and Hatch-Waxman related issues. Ms. Lee has also supported litigation matters from pre-suit investigation and continuing through trial.
Ms. Lee has vast experience with due diligence investigations on proposed transactions across a broad range of technologies, and assists her clients with IP-related agreements associated with technology transfers through acquisition or licensing opportunities. Ms. Lee also conducts freedom to operate and clearance investigations, validity/infringement assessments, and investigates inventorship disputes.
Prior to her legal career, Ms. Lee spent six years in biomedical research in the Department of Anesthesia at the Brigham & Women’s Hospital in Boston, investigating the interaction of opioids and benzodiazepines.